SQ Innovation’s topline data evaluating its Lasix Onyu home care oedema treatment versus SoC IV was shared at the 2026 Heart Failure Congress in Barcelona.

Contains the active ingredient furosemide frusemide. What is in this leaflet This leaflet answers some common questions about this medicine. It does not take the place of talking to your doctor or ...

Company’s furosemide tablets were found to be bioequivalent and have the same therapeutic effect as Aventis’ Lasix tablets The Office of Generic Drugs, FDA, granted Ranbaxy Laboratories (RLL) approval ...

SUBCUT HF II, a randomized controlled investigator-sponsored trial of at-home subcutaneous furosemide for heart failure–related edema, meets its primary and key secondary endpoints, supporting the ...

Furosemide 80mg/2.67mL; per prefilled cartridge (co-packaged with a Disposable Unit of the Infusor); soln for SC infusion. Store between 20°C and 25°C (68°F and 77°F); excursions permitted between ...

SQ Innovation today announced that results of the SUBCUT HF II trial of its product Lasix® ONYU, will be presented at Heart Failure 2026, the annual congress of the Heart Failure Association (HFA) of ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, is introducing Furosemide for Injection, which is the generic of Lasix. Furosemide is indicated in ...

A Prescription Drug User Fee Act target date of July 26, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...